Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Coccidioidomycosis | Kisho | Kisho

Back to Coccidioidomycosis

Coccidioidomycosis — NIH Grants & Funding

Active and recent NIH-funded research on Coccidioidomycosis. Data from NIH RePORTER, last 36 months.

MONDO:0005706

NIH-funded research on Coccidioidomycosis

active grants

institutions

researchers

new in last 12 mo.

$58.2M in NIH funding over the last 36 months. Data from NIH RePORTER.

I'm looking for:

Or filter by research focus

Only show active grants

Basic Science(10)

Basic ScienceR01Active

Airway Innate Immune Responses to Coccidioides Infection

Chen, Yin et al.·UNIVERSITY OF ARIZONA·TUCSON, AZ

$3,075,549 (FY2025)

Coccidioidomycosis — NIH Grants & Funding

Basic Science(10)

Airway Innate Immune Responses to Coccidioides Infection

Molecules and Pathways at the Coccidioides Host-Pathogen Interface

Host Immunogenetics and Fungal Virulence Mechanisms in Coccidioidomycosis

Mechanisms of vaccine immunity against coccidioidomycosis

Immune regulation to Coccidioides infection

Regulation of infectious spore formation in the fungal pathogen Coccidioides posadasii

Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis

A Point-of-Care Test for Rapid Diagnosis of Valley Fever

T-cell Dysfunction as the basis of Disseminated Coccidioidomycosis

Investigation of key proteases in the parasitic phase of Coccidioides

Translational(7)

Identification of Novel Syk/Raf-1 Mediated CLR Ligands as Vaccine Adjuvants

Identification of Novel Syk/Raf-1 Mediated CLR Ligands as Vaccine Adjuvants

SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.

Development of Coccidioides Cytokine Release Assay

Novel antifungal agents against coccidioidomycosis

Development of a multivalent vaccine against Coccidioides infection

Defining the State of CD8+ and CD4+ T cells and the Effect of Antibiotic Treatment on Chronic States of Coccidioidomycosis Disease

Clinical(1)

Mechanisms of Vaccine Immunity against Coccidioidomycosis

Epi / Nat. History(4)

Estimating and understanding implications of population susceptibility to coccidioidomycosis, an emerging infectious disease

Determining the effects of ambient dust exposure and extreme dust events on coccidioidomycosis in Arizona

Modelled estimation of population immunity for coccidioidomycosis and the role of immunologically naïve populations in the shifting epidemiology of coccidioidomycosis in California

Integrating epidemiologic and environmental approaches to understand and predict Coccidioides exposure and coccidioidomycosis emergence

Biomarker / Dx(5)

Serological Biomarkers for Coccidioidomycosis

Proteome-wide Discovery of Diagnostic Targets for Coccidioidomycosis

Optimization of antigen preparations from Coccidioides for diagnostic testing

Breath Volatile Metabolites for the Diagnosis of Coccidioidomycosis

Rational design of a novel rapid diagnostic tool for coccidioidomycosis

Medical Device(2)

Rapid immunoassay for diagnosis of coccidioidomycosis

Development of a dual-iDDS probe multiplex test for detecting endemic fungal agents

Other(1)

Repurposing Drugs to Discover Novel Antifungals for Coccidioidomycosis